Tekmira Pharmaceuticals Corporation

Tekmira Pharmaceuticals Corporation

August 11, 2008 20:17 ET

Tekmira Pharmaceuticals Conference Call Advisory

2008 Quarter Operating Results

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 11, 2008) - Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it will hold a conference call and webcast on Thursday August 14, 2008 at 8:00 am Pacific Time (11:00 am Eastern Time) to discuss second quarter 2008 operating results and to provide an update on developments at the Company.

About the Conference Call

To participate in the conference call, please dial 416-641-6139 or 1-866-299-6657. The call will be available for replay until August 28, 2008 by calling 416-695-5800 or 1-800-408-3053 and entering the pass code 3268488.

The live or archived webcast can also be accessed through the Company's website at www.tekmirapharm.com.

About Tekmira

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi products and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Further information about Tekmira can be found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.

Contact Information

  • Tekmira Pharmaceuticals Corporation - Investors
    Ian Mortimer, Vice President,
    Executive Finance and Chief Financial Officer
    (604) 419-3200
    Website: www.tekmirapharm.com
    Longview Communications Inc. - Media
    David Ryan
    (604) 694-6031
    Email: dryan@longviewcomms.ca